Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Posts Paxil Pediatric Data On Website; Plans U.S. Clinical Trial Register

Executive Summary

GlaxoSmithKline's off-the-shelf response to requests for information about off-label use of Paxil in pediatric patients notes that there are studies demonstrating efficacy of paroxetine in obsessive/compulsive disorder and social anxiety disorder

You may also be interested in...



GSK Settles On Paxil Data Disclosure, Will Post Past Study Results By 2006

GlaxoSmithKline will post summaries of studies conducted since the merger of Glaxo Wellcome and SmithKline Beecham by the end of 2005 under a settlement with New York Attorney General Eliot Spitzer

Clinical Trial Database Endorsed By PhRMA; Proposal Coming Soon

The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products

Clinical Trial Database Endorsed By PhRMA; Proposal Coming Soon

The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products

Related Content

UsernamePublicRestriction

Register

PS044200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel